The Cost Of A Cure: Patent Rights And Drug Prices
U.S. patients pay much higher prices for drugs than patients overseas, effectively subsidizing patients worldwide.
U.S. patients pay much higher prices for drugs than patients overseas, effectively subsidizing patients worldwide.
A federal jury has awarded $2.54 billion in royalties to Merck, ruling against Gilead in a monumental patent infringement case involving two blockbuster hepatitis C drugs.
Depositions by Filevine help with scheduling, tracking goals, and trial prep.